Dr. Philip M. Monteleone
Claim this profileState University of New York Upstate Medical University
Expert in Tumors
Expert in Brain Tumor
59 reported clinical trials
108 drugs studied
Area of expertise
1Tumors
Global LeaderStage I
Stage IV
Stage II
2Brain Tumor
Global LeaderStage I
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Philip M. Monteleone is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Philip M. Monteleone
Clinical Trial Related7 years of experience running clinical trials · Led 59 trials as a Principal Investigator · 26 Active Clinical TrialsTreatments Philip M. Monteleone has experience with
- Cyclophosphamide
- Radiation Therapy
- Etoposide
- Doxorubicin Hydrochloride
- Nivolumab
- Vincristine Sulfate
Breakdown of trials Philip M. Monteleone has run
Tumors
Brain Tumor
Lymphoma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Philip M. Monteleone specialize in?
Philip M. Monteleone focuses on Tumors and Brain Tumor. In particular, much of their work with Tumors has involved Stage I patients, or patients who are Stage IV.
Is Philip M. Monteleone currently recruiting for clinical trials?
Yes, Philip M. Monteleone is currently recruiting for 20 clinical trials in Syracuse New York. If you're interested in participating, you should apply.
Are there any treatments that Philip M. Monteleone has studied deeply?
Yes, Philip M. Monteleone has studied treatments such as Cyclophosphamide, Radiation Therapy, Etoposide.
What is the best way to schedule an appointment with Philip M. Monteleone?
Apply for one of the trials that Philip M. Monteleone is conducting.
What is the office address of Philip M. Monteleone?
The office of Philip M. Monteleone is located at: State University of New York Upstate Medical University, Syracuse, New York 13210 United States. This is the address for their practice at the State University of New York Upstate Medical University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.